Innate immune reprogramming to overcome therapy resistance in high-risk colorectal cancer
Dauer: 36 Monate, Fördersumme: € 800.000
Decoding cellular senescence in glioblastoma (GlioAge)
Dauer: 36 Monate, Fördersumme: € 898.970
Validation of a liquid biopsy based molecular diagnostic toolkit for pediatric sarcomas
Dauer: 48 Monate, Fördersumme: € 899.160
A novel macrophage precursor in adult bone marrow
Dauer: 48 Monate, Fördersumme: € 798.940
Kinetic Theory Applied to the Study of Fertility, Cancer and Development
Dauer: 96 Monate, Fördersumme: € 1.575.460
Ultra-high-risk pediatric cancer - combinatorial drivers and therapeutic targets for precision medicine
Dauer: 36 Monate, Fördersumme: € 799.350